- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/38 - Albumins
Patent holdings for IPC class A61K 38/38
Total number of patents in this class: 853
10-year publication summary
75
|
99
|
71
|
98
|
93
|
71
|
87
|
72
|
77
|
10
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Abraxis BioScience, LLC | 213 |
23 |
Alkahest, Inc. | 95 |
21 |
The Regents of the University of California | 18943 |
16 |
Selecta Biosciences, Inc. | 190 |
14 |
Ampio Pharmaceuticals, Inc. | 46 |
13 |
Ecole Polytechnique Federale de Lausanne (epfl) | 1434 |
13 |
Zhuhai Beihai Biotech Co., Ltd. | 42 |
13 |
Comera Life Sciences, Inc. | 34 |
12 |
Grifols Worldwide Operations Limited | 303 |
11 |
Société des Produits Nestlé S.A. | 9672 |
10 |
The Brigham and Women's Hospital, Inc. | 2087 |
10 |
Novartis AG | 11238 |
9 |
The Johns Hopkins University | 5377 |
9 |
Mayo Foundation for Medical Education and Research | 2981 |
8 |
Bioverativ Therapeutics Inc. | 220 |
8 |
Hamlet Pharma AB | 17 |
8 |
Albumedix Ltd | 69 |
8 |
Baxter International Inc. | 2425 |
6 |
Baxter Healthcare S.A. | 1810 |
6 |
CSL Behring GmbH | 350 |
6 |
Other owners | 629 |